{"url_path":"/sec/mrkr/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html","accession_number":"0001104659-26-062763","cik":"0001094038","ticker":"MRKR","issuer_name":"Marker Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1094038/0001104659-26-062763-index.html","primary_entity_key":"0001094038","primary_entity_name":"Marker Therapeutics, Inc."},"word_count":103,"has_tables":true,"body_markdown":"**Item 1A.       Risk Factors**\n\nOur business is subject to risks and events that, if they occur, could adversely affect our financial condition and results of operations and the trading price of our securities. In addition to the other information set forth in this quarterly report on Form 10-Q, you should carefully consider the factors described in Part I, Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on March 18, 2026. There have been no material changes to the risk factors described in that report.\n\n​"}